Ventracor Limited supplies cardiac assist systems. It engages in the research, development, manufacture, and commercialization of a Left Ventricular Assist Device (LVAD) and other related technologies. Its core product is VentrAssist LVAD, an implantable blood pump designed as an alternative to heart transplants for patients suffering heart failure. The company operates in Australia, the United States, and Europe. Ventracor Limited is headquartered in Chatswood, Sydney, Australia. As of Feb 2009, the VentrAssist has been implanted in over 400 patients worldwide. Ventracor was previously know as MicroMedical.
